Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study

Autor: Royal, V, Leung, N, Troyanov, S, Nasr, Sh, Écotière, L, LeBlanc, R, Adam, BA, Angioi, A, Alexander, MP, Asunis, AM, Barreca, A, Bianco, PC, Cohen, C, Drosou, ME, Fatima, H, Fenoglio, R, Gougeon, F, Goujon, JM, Herrera, GA, Knebelmann, B, Lepori, N, Maletta, F, Manso, RT, Motwani, SS, Pani, A, Rabant, M, Rennke, HG, Rocatello, D, Rosenblum, F, Sanders, PW, Santos, A, Soto, K, et al.

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Light chain cast nephropathy (LCCN) in multiple myeloma often leads to severe and poorly reversible acute kidney injury. Severe renal impairment influences the allocation of chemotherapy and its tolerability; it also affects patient survival. Whether

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::74f85e9ff248e5b3eae08bf58e10bf74
https://hdl.handle.net/10400.10/2455